Scanis took a major step forward this month in laying the groundwork for commercial launch of its Mammex TR computer-aided detection workstation. The Foster City, CA, company has signed a letter of intent to set up a worldwide distribution deal for
Scanis took a major step forward this month in laying the groundwork for commercial launch of its Mammex TR computer-aided detection workstation. The Foster City, CA, company has signed a letter of intent to set up a worldwide distribution deal for Mammex TR with mammography heavyweight Trex Medical of Danbury, CT.
The agreement calls for Trex to receive exclusive worldwide sales and marketing rights to the workstation for five years. Mammex TR could be used either with Trex's full-field digital mammography system or with digitized mammography film to flag suspicious areas on an image for a radiologist's attention. Mammex TR will be shown as a work-in-progress at this month's Radiological Society of North America meeting.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.